Diagnocure, Inc.
Diagnocure, Inc.
Your view on DGCRF
Overview
What the company does, where it operates, and who runs it.
About Diagnocure, Inc.
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Yves Fradet F.R.C.S.,
- Headquarters
- 4535 Wilfrid-Hamel Boulevard, Quebec, QC, CA
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Yves Fradet F.R.C.S.,
- Headquarters
- 4535 Wilfrid-Hamel Boulevard, Quebec, QC, CA
Diagnocure, Inc., a life sciences company, develops and commercializes products relating to the diagnosis of cancer in Canada. It focuses on molecular diagnostic tests for the detection and management of cancer. The company offers PCA3 test for the diagnosis of prostate cancer; and Guanylyl Cyclase C (GCC) marker and Previstage GCC colorectal cancer staging test for colorectal cancer patients, as well as PCP, a multi marker prostate cancer test. It also provides gene expression and copy number variation analysis, mutation detection, SNP genotyping, and platform and laboratory environmental services. The company was formerly known as DiagnoCure Inc. 9342-8530 Québec Inc. was founded in 1994 and is headquartered in Quebec, Canada.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.